Jyoti Global (JYOTIGLOBL)

Score breakdown: P/E: 2/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• ROCE of 23.71% indicates strong capital efficiency for a small packaging firm
• Profit growth of 20.69% outpaces sales growth of 10.78%, suggesting improving margins or operating leverage
• Piotroski F-score of 7/9 points to solid fundamentals and decent financial health
• Promoter holding of 72.91% aligns management interests with minority shareholders
• PEG of 0.82 and P/E of 12.92 offer reasonable valuation relative to earnings growth

Concerns

• Zero dividend means minority shareholders receive no cash return while the business reinvests
• No book value or debt-to-equity data makes full balance sheet assessment difficult
• Small market cap of ₹86 Cr and high promoter holding imply low free float and possible price volatility
• Packaging is a competitive industry, and no clear durable moat is evident from the data

AI Analysis

At ₹44, Jyoti Global is a small packaging player with a market cap of only ₹86 Cr. I start with size: it is tiny, so I would only consider it as a very small satellite position after checking management integrity. The business earns a return on capital employed of 23.71%, which is genuinely attractive and suggests it does not need heavy assets to generate profits. Profit growth of 20.69% is nicely ahead of sales growth of 10.78%, indicating operating leverage or improving margins in the packaging niche. A P/E of 12.92, combined with a PEG of 0.82, says the market is not paying a fancy price for this growth. That appeals to the Graham bargain instinct. The Piotroski F-score of 7 out of 9 supports the idea that financial health is respectable. Promoter holding of 72.91% aligns owners with minority shareholders, although it also reduces free float and could make the stock volatile. I am bothered by zero dividend: I like managements that return cash when they cannot reinvest profitably, especially in a competitive packaging business with no obvious moat. Also, I have no book value or debt-to-equity data, so I cannot fully judge the balance sheet cushion. At ₹44, the stock sits above the midpoint of its 52-week range, so I am not getting a distressed bargain. For me, this is a decent, small compounder candidate, but not a clear wonderful business at a fair price. I would need more years of consistent numbers and a clearer competitive edge before treating it as a core holding.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer